Drug Shortage Report for METHYLENE BLUE INJECTION USP

Last updated on 2023-01-27 History
Report ID 173088
Drug Identification Number 02230770
Brand name METHYLENE BLUE INJECTION USP
Common or Proper name Methylene Blue Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) METHYLENE BLUE
Strength(s) 10MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 5 mL vial / fiole
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-10-28
Estimated end date 2023-02-03
Actual end date 2023-01-26
Shortage status Resolved
Updated date 2023-01-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v23 2023-01-27 English Compare
v22 2023-01-26 French Compare
v21 2023-01-26 English Compare
v20 2023-01-13 French Compare
v19 2023-01-13 English Compare
v18 2022-12-20 French Compare
v17 2022-12-20 English Compare
v16 2022-12-08 French Compare
v15 2022-12-08 English Compare
v14 2022-11-25 French Compare
v13 2022-11-25 English Compare
v12 2022-11-15 French Compare
v11 2022-11-15 English Compare
v10 2022-11-11 French Compare
v9 2022-11-11 English Compare
v8 2022-11-08 French Compare
v7 2022-11-08 English Compare
v6 2022-11-04 French Compare
v5 2022-11-04 English Compare
v4 2022-10-29 English Compare

Showing 1 to 20 of 23